LINC02894: A Potential Drug Target and Biomarker (G100288748)

Target Name: LINC02894

NCBI ID: G100288748

LINC02894

Other Name(s): long intergenic non-protein coding RNA 2894 | Long intergenic non-protein coding RNA 2894

LINC02894: A Potential Drug Target and Biomarker

LINC02894 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the cell's intercellular communication, which is a critical aspect of various physiological processes in the body. LINC02894 is expressed in many different tissues and cells, including the brain, pancreas, and gastrointestinal tract. Its function is not well understood, but it is believed to play a role in the regulation of various cellular processes, including cell survival, migration, and angiogenesis.

One of the key features of LINC02894 is its ability to interact with various protein molecules. It has been shown to interact with several different proteins, including the protein known as PDGF-BB. PDGF-BB is a potent regulator of cell growth and differentiation, and it is involved in the development and maintenance of tissues and organs. LINC02894 has been shown to physically interact with PDGF-BB, which suggests that it may play a role in the regulation of these processes.

Another potential drug target for LINC02894 is its role in the regulation of cell death. It has been shown to be involved in the regulation of apoptosis, which is a natural process that helps the body to remove damaged or dysfunctional cells. Abnormal cell death, or apoptosis, can contribute to a wide range of diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. LINC02894 may be a potential drug target for these conditions because it is involved in the regulation of cell death.

In addition to its potential drug target properties, LINC02894 is also a potential biomarker. Its expression has been shown to be regulated by various factors, including DNA methylation, histone modification, and post-transcriptional modification. This suggests that LINC02894 may be involved in the regulation of cellular processes that are critical for its own survival and function. It may also be a useful biomarker for the diagnosis and prognosis of various diseases.

Overall, LINC02894 is a promising candidate for further research as a drug target and biomarker. Its interaction with PDGF-BB and its potential role in the regulation of cell death and apoptosis make it a promising target for drug development. Further studies are needed to fully understand its function and its potential as a biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 2894

The "LINC02894 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02894 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets